Alexander Mark Schobel - Chief Innovation/Tech Officer at Aquestive Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Innovation/Tech Officer
Stock Symbol
AQST on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Alexander Mark Schobel - trading volume in the past year for Aquestive Therapeutics, Inc.

Holdings reported by Alexander Mark Schobel for Aquestive Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 984K $4.8M $4.88 Mar 15, 2024 Direct
Performance Stock Units 50K Aug 9, 2023 Direct Common Stock
Non-Qualified Stock Option (right to buy) 41.3K Mar 7, 2024 Direct Common Stock

Transactions reported by Alexander Mark Schobel for Aquestive Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.